Generics 7

Biosimilars

Medical devices

Nutraceuticals

Filters

Ambrisentan manufacturers

7 products found

Filters

7 products found

ambrisentan

Tablets, film coated 5mg, 10mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

Manufacturer #337

A pharmaceutical manufacturer based in the EU that has been active in 90+ countries selling its products in the EU, Africa, North America, Middle East, and Asia for 30+ years. Key production lines are Rx and OTC. Main therapeutic areas include diabetes, CNS, and dermatology. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 5 days

ambrisentan

Tablets, film coated 2.5mg, 5mg, 10mg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

Manufacturer #260

Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

ambrisentan

Tablets 5mg, 10mg

Dossier type
US CTD
Country of origin
United States
Dossier status
Ready
GMP approvals
FDA

Manufacturer #19592

Manufacturer usually replies in 2 days

Want to view all 7 products? Create your free account today!

What is the Ambrisentan drug?

Ambrisentan is an endothelin receptor antagonist. Ambrisentan will act by relaxing the muscles that are constricted in blood vessels by the peptide endothelin and causing blood pressure. Ambrisentan drug is used to treat PAH (Pulmonary Artery Hypertension); it means high blood pressure in the lungs. Taking Ambristentan medicine is not only to treat pulmonary hypertension but also to improve the exercise ability of the patient.
The FDA approved Ambrisentan in 2007 and the European Medicines Agency. It is considered as an orphan drug.

Ambrisentan manufacturers and wholesalers:

Ambrisentan is known under different brand names; probably, the most known is Letairis from the manufacturer Gilead in the US. In the EU, the brand name is Volibris, in India Pulmonext by the MSN Labs, Ambrican by Lupin, Endobloc by Cipla Ltd, and in Germany, the brand name is Zambri by German Remedies Ltd.
The FDA approved the Ambrisentan generic to four manufacturers: Mylan Pharmaceuticals, Watson Laboratories, Sun Pharma Global, and Zydus Pharmaceuticals. The Ambrisentan drug is found globally.
Ambrisentan suppliers market it in the form of oral tablets of 5 mg and 10 mg.

Ambrisentan for sales:

In the US, Ambrisentan under the name Letairis can cost from $233.27 to $258.55 per oral tablet of 5 mg or 10mg. In France, Ambrisentan, under the name Volibris, costs around 72 € without tax per tablet.
As Ambrisentan is available globally, fraudulent online pharmacies may attempt to sell an illegal generic version of Ambrisentan. Thanks to Pipelinepharma online marketplace, you can be sure of the qualifications of the sellers because they all have been through quality control procedures. Plus, being sure your future partner is qualified, you will save time sourcing for the product and buyer or seller, because it is all in one safe place: Pipelinepharma B2B marketplace. On the platform, you can easily place orders for any pharmaceutical products, including Ambrisentan. From our online marketplace, Ambrisentan is mostly available from the European Union (the Czech Republic and Greece) and Argentina.

How to use Ambrisentan drugs?

To treat PAH, an adult should take the initial dose of 5 mg of Ambrisentan orally once a day. A pregnant woman or a woman who is planning to get pregnant should avoid at all costs taking the Ambrisentan drug because it can cause severe birth defects.
Taking Ambrisentan can have some side effects, the most common ones are: bloating or swelling of the face, arms, hands, lower legs, or feet, rapid weight gain, tingling of the hands or feet, unusual weight gain or loss.